AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33620516 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of a diagnostic RA code with biologic infusion codes
Number of subjects: 87
Study 33620516 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumatologist-reported diagnoses and ACR/EULAR classification criteria
Number of subjects: 87
Study 33620516 — intervention group
Group type: EXPERIMENTAL
Intervention: ACR/EULAR classification criteria
Number of subjects: 87
Study 33620516 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital discharge diagnostic codes
Number of subjects: 87
Study 35333616 — intervention group
Group type: EXPERIMENTAL
Intervention: Antireflux gastric bypass (ARGB)
Number of subjects: 56
Study 35333616 — intervention group
Group type: COMPARATOR
Intervention: Fundoplication
Number of subjects: 56
Study 32901996 — intervention group
Group type: EXPERIMENTAL
Intervention: 15°C PCM treatment covering the quadriceps for three hours
Number of subjects: 30
Study 32901996 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 33831022 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 123
Study 33831022 — intervention group
Group type: EXPERIMENTAL
Intervention: Mind-body breathing (MBB)
Number of subjects: 123
Study 33831022 — intervention group
Group type: COMPARATOR
Intervention: Education control (EDU)
Number of subjects: 123
Study 33831022 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (TC, MBB, EDU)
Number of subjects: 123
Study 35193609 — intervention group
Group type: COMPARATOR
Intervention: Bovine milk-based formula containing L. reuteri DSM 17938 at 1 × 10^7 CFU/g (Control Group; CG)
Number of subjects: 289
Study 35193609 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine milk-based formula with added 1.0 g/L 2'FL (Experimental Group; EG)
Number of subjects: 289
Study 36468967 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.4% silymarin cream
Number of subjects: 25
Study 36468967 — intervention group
Group type: COMPARATOR
Intervention: 2% hydroquinone cream
Number of subjects: 25
Study 32649390 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (1%) eyedrops
Number of subjects: 36
Study 32649390 — intervention group
Group type: COMPARATOR
Intervention: Preservative‐free artificial tears (control group)
Number of subjects: 36
Study 32233208 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound Amino Acid Capsules (CAAC) combined with clomiphene for 12 weeks
Number of subjects: 104
Study 32233208 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene only for 12 weeks
Number of subjects: 104
Study 35963826 — intervention group
Group type: COMPARATOR
Intervention: Standard Xpert/no chest radiography (CXR)
Number of subjects: 640
Study 35963826 — intervention group
Group type: COMPARATOR
Intervention: Standard Xpert/CXR
Number of subjects: 640
Study 35963826 — intervention group
Group type: COMPARATOR
Intervention: Xpert Ultra/no CXR
Number of subjects: 640
Study 35963826 — intervention group
Group type: COMPARATOR
Intervention: Xpert Ultra/CXR
Number of subjects: 640
Study 35963826 — intervention group
Group type: EXPERIMENTAL
Intervention: Xpert Ultra (Arms 3 and 4)
Number of subjects: 640
Study 35963826 — intervention group
Group type: EXPERIMENTAL
Intervention: X-ray group (Arms 2 and 4)
Number of subjects: 640
Study 33567135 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcuticular suturing and early scar management with non‐ablative fractional laser (NAFL) and intralesional triamcinolone injection (ILI)
Number of subjects: 126
Study 33567135 — intervention group
Group type: COMPARATOR
Intervention: Tissue adhesive only
Number of subjects: 126
Study 33567135 — intervention group
Group type: COMPARATOR
Intervention: Skin closure with tissue adhesive and early scar management
Number of subjects: 126
Study 33595631 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid minimally invasive esophagectomy (HMIE)
Number of subjects: 207
Study 33595631 — intervention group
Group type: COMPARATOR
Intervention: Open esophagectomy
Number of subjects: 207
Study 33595631 — intervention group
Group type: EXPERIMENTAL
Intervention: Major intraoperative and postoperative complications
Number of subjects: 207
Study 33595631 — intervention group
Group type: EXPERIMENTAL
Intervention: Major pulmonary complications
Number of subjects: 207
Study 32128725 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic hematopoietic cell transplantation (alloHCT)
Number of subjects: 440
Study 32128725 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy only
Number of subjects: 440
Study 33620301 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality salience condition
Number of subjects: 146
Study 33620301 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 146
Study 34593040 — intervention group
Group type: EXPERIMENTAL
Intervention: Make Safe Happen® app
Number of subjects: 5032
Study 33593156 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based memory rehabilitation intervention
Number of subjects: 24
Study 34890063 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training program
Number of subjects: 28
Study 34890063 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical care
Number of subjects: 28
Study 32164719 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture on HT 7
Number of subjects: 120
Study 32164719 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture on SP 6
Number of subjects: 120
Study 32164719 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture on HT 7 and SP 6
Number of subjects: 120
Study 32164719 — intervention group
Group type: COMPARATOR
Intervention: Compensatory acupuncture therapy (Control)
Number of subjects: 120
Study 32164719 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysomnography (secondary outcome)
Number of subjects: 120
Study 32164719 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomarker measurements (secondary outcome)
Number of subjects: 120
Study 34989824 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole once-monthly (AOM) at 400 mg
Number of subjects: 436
Study 34989824 — intervention group
Group type: COMPARATOR
Intervention: Oral aripiprazole at 10-20 mg
Number of subjects: 436
Study 34989824 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 436
Study 32183750 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieved lenticule thickness measured with ultrasound pachymetry
Number of subjects: 184
Study 32183750 — intervention group
Group type: COMPARATOR
Intervention: Predicted lenticule thickness
Number of subjects: 184
Study 32183750 — intervention group
Group type: EXPERIMENTAL
Intervention: ΔLT
Number of subjects: 184
Study 35974668 — intervention group
Group type: EXPERIMENTAL
Intervention: CTC 200 mg BID
Number of subjects: 1138
Study 35974668 — intervention group
Group type: COMPARATOR
Intervention: Tramadol 100 mg QID
Number of subjects: 1138
Study 35974668 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1138
Study 36122660 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective laser trabeculoplasty (SLT)
Number of subjects: 524
Study 36122660 — intervention group
Group type: COMPARATOR
Intervention: Eye drops
Number of subjects: 524
Study 33066805 — intervention group
Group type: EXPERIMENTAL
Intervention: Moodbuster Lite with automated support delivered by a virtual coach
Number of subjects: 70
Study 33066805 — intervention group
Group type: COMPARATOR
Intervention: Moodbuster Lite without automated support
Number of subjects: 70
Study 35174869 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive circuit class therapy
Number of subjects: 46
Study 35174869 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study 34833364 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) combined with visual cueing training
Number of subjects: 30
Study 34833364 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS combined with visual cueing training
Number of subjects: 30
Study 32075673 — intervention group
Group type: EXPERIMENTAL
Intervention: multicomponent training associated with active tDCS
Number of subjects: 28
Study 32075673 — intervention group
Group type: COMPARATOR
Intervention: multicomponent training associated with sham tDCS
Number of subjects: 28
Study 36456965 — intervention group
Group type: EXPERIMENTAL
Intervention: eAEP (online education program)
Number of subjects: 100
Study 36456965 — intervention group
Group type: COMPARATOR
Intervention: usual care (including referral to fAEP)
Number of subjects: 100
Study 36456965 — intervention group
Group type: EXPERIMENTAL
Intervention: eAEP
Number of subjects: 100
Study 36334895 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback on radiation protection performance after each case (n=12)
Number of subjects: 24
Study 36334895 — intervention group
Group type: COMPARATOR
Intervention: No feedback on radiation protection performance (Control group, n=12)
Number of subjects: 24
Study 32530343 — intervention group
Group type: EXPERIMENTAL
Intervention: vNOTES hysterectomy
Number of subjects: 99
Study 32530343 — intervention group
Group type: COMPARATOR
Intervention: TLH hysterectomy
Number of subjects: 99
Study 35862105 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-based interactive cognitive training (VICT) system
Number of subjects: 26
Study 33745454 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity fitness training
Number of subjects: 20
Study 33745454 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity exercise (Control)
Number of subjects: 20
Study 32302322 — intervention group
Group type: EXPERIMENTAL
Intervention: Indemnity (conditional cash transfers)
Number of subjects: 3000
Study 32302322 — intervention group
Group type: COMPARATOR
Intervention: Standard insurance
Number of subjects: 3000
Study 34953634 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh mango consumption (100 kcal/d)
Number of subjects: 27
Study 34953634 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric low-fat cookies (100 kcal/d)
Number of subjects: 27
Study 34965036 — intervention group
Group type: EXPERIMENTAL
Intervention: Early precut fistulotomy (5 minutes after failed standard biliary cannulation)
Number of subjects: 40
Study 34965036 — intervention group
Group type: COMPARATOR
Intervention: Late precut fistulotomy (15 minutes after failed standard biliary cannulation)
Number of subjects: 40
Study 33783006 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-treatment with pan-genotypic DAA (sofosbuvir and velpatasvir with or without ribavirin)
Number of subjects: 40
Study 36214029 — intervention group
Group type: EXPERIMENTAL
Intervention: Online learning (2020)
Number of subjects: 98
Study 36214029 — intervention group
Group type: COMPARATOR
Intervention: Traditional learning (2021)
Number of subjects: 98
Study 32016881 — intervention group
Group type: EXPERIMENTAL
Intervention: Better sleep quality
Number of subjects: 1444
Study 32016881 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter time to fall asleep
Number of subjects: 1444
Study 32192917 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitored Anesthesia Care (MAC)
Number of subjects: 3110
Study 32192917 — intervention group
Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 3110
Study 34558198 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial funding
Number of subjects: 6841
Study 34558198 — intervention group
Group type: COMPARATOR
Intervention: Unpublished data on funding source
Number of subjects: 6841
Study 34343240 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic control method
Number of subjects: 0
Study 34343240 — intervention group
Group type: COMPARATOR
Intervention: Unexposed controls
Number of subjects: 0
Study 32532767 — intervention group
Group type: EXPERIMENTAL
Intervention: Accredited general practice (recent accreditation)
Number of subjects: 3609
Study 32532767 — intervention group
Group type: EXPERIMENTAL
Intervention: Accredited general practice (previous accreditation)
Number of subjects: 3609
Study 32532767 — intervention group
Group type: EXPERIMENTAL
Intervention: Accredited general practice (2016)
Number of subjects: 3609
Study 32532767 — intervention group
Group type: EXPERIMENTAL
Intervention: Accredited general practice (2017)
Number of subjects: 3609
Study 36472389 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery (SRS)
Number of subjects: 0
Study 36472389 — intervention group
Group type: COMPARATOR
Intervention: Whole-brain radiation therapy (WBRT)
Number of subjects: 0
Study 33617632 — intervention group
Group type: EXPERIMENTAL
Intervention: ATX-101
Number of subjects: 224
Study 33617632 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224
Study 32723925 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotary exercise program
Number of subjects: 31
Study 32723925 — intervention group
Group type: COMPARATOR
Intervention: Traditional 'core' exercise program
Number of subjects: 31
Study 34741341 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary mulberry-leaf flavonoids (MF) 30 mg/kg
Number of subjects: 270
Study 34741341 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary mulberry-leaf flavonoids (MF) 60 mg/kg
Number of subjects: 270
Study 34741341 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary mulberry-leaf flavonoids (MF)
Number of subjects: 270
Study 34106599 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 252
Study 34106599 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation training
Number of subjects: 252
Study 34494681 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone behavioral health counseling
Number of subjects: 240
Study 34494681 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic-based behavioral health counseling
Number of subjects: 240
Study 34494681 — intervention group
Group type: COMPARATOR
Intervention: Attention control nutrition education
Number of subjects: 240
Study 34494681 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counseling
Number of subjects: 240
Study 34494681 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic-based counseling
Number of subjects: 240
Study 32878820 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirarubicin (THP)
Number of subjects: 103
Study 32878820 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin C (MMC)
Number of subjects: 103
Study 35197018 — intervention group
Group type: EXPERIMENTAL
Intervention: Goldilocks Work intervention
Number of subjects: 28
Study 32913130 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Skills for Students (MSS)
Number of subjects: 616
Study 32913130 — intervention group
Group type: COMPARATOR
Intervention: Support as usual (SAU)
Number of subjects: 616
Study 32996842 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based legacy intervention (digital storyboards, legacy questions, photographs, video, music)
Number of subjects: 150
Study 32996842 — intervention group
Group type: COMPARATOR
Intervention: Usual care (wait-list control)
Number of subjects: 150
Study 36401233 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal injection of triamcinolone acetonide (IVTA) combined with standard phacoemulsification surgery
Number of subjects: 50
Study 36401233 — intervention group
Group type: COMPARATOR
Intervention: Routine phacoemulsification surgery (Control)
Number of subjects: 50
Study 36196727 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D and omega-3 polyunsaturated fatty acid (PUFA) co-supplementation (VIDOM)
Number of subjects: 0
Study 36196727 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33444116 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin (AUC 5) plus Paclitaxel (175 mg/m2) plus Bevacizumab (5 mg/kg) every 2 weeks (CPB arm)
Number of subjects: 114
Study 33444116 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin (AUC 5) plus Paclitaxel (175 mg/m2) without Bevacizumab (CP arm)
Number of subjects: 114
Study 32559656 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive feedback on ToM performance
Number of subjects: 131
Study 32559656 — intervention group
Group type: COMPARATOR
Intervention: Negative feedback on ToM performance
Number of subjects: 131
Study 32559656 — intervention group
Group type: COMPARATOR
Intervention: No feedback on ToM performance
Number of subjects: 131
Study 36378308 — intervention group
Group type: EXPERIMENTAL
Intervention: Quaternary ammonium, salt‐based, 24‐hour continuously active germicidal wipe
Number of subjects: 50
Study 36378308 — intervention group
Group type: COMPARATOR
Intervention: Routine disinfection (Control)
Number of subjects: 50
Study 32050238 — intervention group
Group type: EXPERIMENTAL
Intervention: White-to-white (WTW) distance measurement
Number of subjects: 65
Study 32050238 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontal WTW measurement without adjustment
Number of subjects: 65
Study 32050238 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical STS meridian measurement
Number of subjects: 65
Study 32050238 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of AS-OCT
Number of subjects: 65
Study 32050238 — intervention group
Group type: EXPERIMENTAL
Intervention: AC IOL placement orientation
Number of subjects: 65
Study 36473191 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Cyclosporin A 0.1% (CsA), once daily for 12 weeks
Number of subjects: 279
Study 36473191 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Diquafosol Tetrasodium 3% (DQS), six times a day for 12 weeks
Number of subjects: 279
Study 36473191 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of CsA and DQS, for 12 weeks
Number of subjects: 279
Study 34051812 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-gene prediction model for AML survival
Number of subjects: 0
Study 32919916 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan therapy
Number of subjects: 8399
Study 32919916 — intervention group
Group type: COMPARATOR
Intervention: ICD use
Number of subjects: 8399
Study 33208340 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (P) weekly × 12 plus carboplatin AUC6 every 21 days × 4 followed by doxorubicin/cyclophosphamide (AC) every 14 days × 4 (CbP → AC, arm A)
Number of subjects: 100
Study 33208340 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin AUC6 + docetaxel (D) every 21 days × 6 (CbD, arm B)
Number of subjects: 100
Study 35442870 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 85
Study 35442870 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 85
Study 33452004 — intervention group
Group type: EXPERIMENTAL
Intervention: FIL200 + MTX
Number of subjects: 1252
Study 33452004 — intervention group
Group type: EXPERIMENTAL
Intervention: FIL100 + MTX
Number of subjects: 1252
Study 33452004 — intervention group
Group type: EXPERIMENTAL
Intervention: FIL200 monotherapy
Number of subjects: 1252
Study 33452004 — intervention group
Group type: COMPARATOR
Intervention: MTX
Number of subjects: 1252
Study 33998550 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper limbs cycle ergometer (ULCE) combined with conventional physiotherapy
Number of subjects: 20
Study 33998550 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 20
Study 32600764 — intervention group
Group type: COMPARATOR
Intervention: 0% glucose inclusion (L1, n = 20)
Number of subjects: 100
Study 32600764 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% glucose inclusion (L2, n = 20)
Number of subjects: 100
Study 32600764 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% glucose inclusion (L3, n = 20)
Number of subjects: 100
Study 32600764 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% glucose inclusion (L4, n = 20)
Number of subjects: 100
Study 32600764 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% glucose inclusion (L5, n = 20)
Number of subjects: 100
Study 34327739 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK3335065 (1.3 mg)
Number of subjects: 0
Study 34327739 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 0
Study 33938787 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP plus usual care (n=55)
Number of subjects: 108
Study 33938787 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone (control, n=54)
Number of subjects: 108
Study 33938787 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP group (n=55)
Number of subjects: 108
Study 33938787 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=54)
Number of subjects: 108
Study 32453369 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg orally twice daily for 2 years (n=133)
Number of subjects: 261
Study 32453369 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=128)
Number of subjects: 261
Study 32453369 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 261
Study 32453369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 261
Study 36350138 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning algorithm (random forest model) for predicting optimal cytoreduction (<1 cm) and no gross residual (RD = 0 mm).
Number of subjects: 151
Study 36350138 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning algorithm (random forest model) for predicting no gross residual (RD = 0 mm).
Number of subjects: 151
Study 34162759 — intervention group
Group type: EXPERIMENTAL
Intervention: Maccabi Telecare Center (MTC) intervention
Number of subjects: 0
Study 35930057 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive shocks (3×5 minutes)
Number of subjects: 8
Study 35930057 — intervention group
Group type: COMPARATOR
Intervention: Random vibration (1×5 minutes)
Number of subjects: 8
Study 35930057 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive shocks
Number of subjects: 8
Study 32012231 — intervention group
Group type: EXPERIMENTAL
Intervention: Radotinib 300 mg
Number of subjects: 241
Study 32012231 — intervention group
Group type: EXPERIMENTAL
Intervention: Radotinib 400 mg
Number of subjects: 241
Study 32012231 — intervention group
Group type: COMPARATOR
Intervention: Imatinib 400 mg
Number of subjects: 241
Study 36438801 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg/kg of vancomycin every 12 h
Number of subjects: 56
Study 36438801 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg/kg of vancomycin every 8 h
Number of subjects: 56
Study 36438801 — intervention group
Group type: COMPARATOR
Intervention: Control group (every 12 h)
Number of subjects: 56
Study 36438801 — intervention group
Group type: COMPARATOR
Intervention: Control group (every 8 h)
Number of subjects: 56